Insulin-like growth factor-1 stimulates production of mesangial cell matrix components
- PMID: 7554520
Insulin-like growth factor-1 stimulates production of mesangial cell matrix components
Abstract
Diabetic nephropathy is characterized by mesangial cell proliferation and expansion of the mesangial matrix. Insulin-like growth factor-1 (IGF-1) increases in the kidney early in experimental diabetes. The effect of IGF-1 on mesangial cell proliferation and synthesis of extracellular matrix (ECM) proteins was examined to test the hypothesis that IGF-1 stimulates mesangial cells to synthesize ECM proteins. ECM proteins were measured by immunoprecipitation after metabolic labeling of rat mesangial cells in culture. IGF-1 caused a 2.4-fold increase in mesangial cell proliferation as measured by 3H-thymidine incorporation. IGF-1 caused an increase in cellular laminin, fibronectin and type IV collagen, 46.8 +/- 15.4%, 31.3 +/- 11.4%, and 27.7 +/- 12.6% increase respectively compared to control cells. IGF-1 did not effect cellular type 1 collagen, decrease of 8.2 +/- 8.7%. There was a trend toward increased total protein synthesis by IGF-1, 36.5 +/- 2.5%. In summary, IGF-1 stimulates ECM component production by mesangial cells. Thus, IGF-1 has the capacity to mediate the histologic changes characteristic of diabetic nephropathy.
Similar articles
-
IGF-1 increases laminin, cyclin D1, and p21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression.J Cell Biochem. 2006 May 1;98(1):208-20. doi: 10.1002/jcb.20771. J Cell Biochem. 2006. PMID: 16408277
-
Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.Diabetes. 1997 Nov;46(11):1881-7. doi: 10.2337/diab.46.11.1881. Diabetes. 1997. PMID: 9356040
-
SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.J Cell Biochem. 2003 Mar 1;88(4):802-11. doi: 10.1002/jcb.10424. J Cell Biochem. 2003. PMID: 12577314
-
[Abnormality of type IV collagen metabolism in the development of diabetic nephropathy].Nihon Rinsho. 1992 Dec;50(12):3016-20. Nihon Rinsho. 1992. PMID: 1491453 Review. Japanese.
-
[Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].Rinsho Byori. 2011 Feb;59(2):179-86. Rinsho Byori. 2011. PMID: 21476304 Review. Japanese.
Cited by
-
Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts.Arthritis Res Ther. 2006;8(6):R177. doi: 10.1186/ar2087. Arthritis Res Ther. 2006. PMID: 17129375 Free PMC article.
-
Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.Signal Transduct Target Ther. 2020 Feb 14;5(1):9. doi: 10.1038/s41392-020-0106-1. Signal Transduct Target Ther. 2020. PMID: 32296020 Free PMC article. Review.
-
The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.Kidney Res Clin Pract. 2012 Mar;31(1):26-37. doi: 10.1016/j.krcp.2011.12.005. Epub 2012 Jan 17. Kidney Res Clin Pract. 2012. PMID: 26889406 Free PMC article. Review.
-
IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells.Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C122-30. doi: 10.1152/ajpcell.00141.2011. Epub 2011 Sep 21. Am J Physiol Cell Physiol. 2012. PMID: 21940672 Free PMC article.
-
Serum arylhydrocarbon receptor transactivating activity is elevated in type 2 diabetic patients with diabetic nephropathy.J Diabetes Investig. 2013 Sep 13;4(5):483-91. doi: 10.1111/jdi.12081. Epub 2013 Apr 22. J Diabetes Investig. 2013. PMID: 24843699 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous